Tallaght University Hospital
Cancer Medicine (Medical Oncology)
The medical oncology service in Tallaght University Hospital (TUH) works with colleagues across medical and surgical disciplines in the Hospital to diagnose and treat patients with cancer.
Treatments for cancer include surgery, medication therapy including chemotherapy, radiation therapy, as well as newer techniques such as interventional radiology techniques. In medical oncology we use medications to treat cancer. This includes chemotherapy, targeted therapies and immunotherapy, depending on the cancer type we are treating. Our oncologists also have a presence in Naas General Hospital where they run satellite clinics on a weekly basis.
We look after people with many types of cancer and related diseases, including:
- Bladder cancer
- Upper gastrointestinal tract cancer (oesophageal, stomach)
- Colorectal cancer
- Kidney cancer
- Liver cancer
- Pancreatic cancer
- Lung cancer
- Melanoma
- Prostate cancer
- Testicular cancer
Amber Oncology Day Ward (ODW)The Amber Oncology Day ward is one of type two national designated National Cancer Control Programme (NCCP) Systemic Anti-Cancer Therapy day units. Here, in the Oncology Dayward we work with valued colleagues across the HSE in the community and other hospitals across the country. The Oncology Dayward is a specialised medical facility that provides outpatient care and treatment for cancer patients. Patients visiting the Oncology Dayward typically do not require an overnight stay in hospital and receive treatments such as chemotherapy, immunotherapy and supportive care during the day. The goal of the Oncology Dayward is to provide comprehensive care in a comfortable and supportive environment while enabling patients to go home the same day. We also provide the Paxman Cold Cap machines and we have the ability to treat four patients with the cold cap at any one time. TUH was the first hospital in the country to use these cold cap machines to prevent hair loss during chemotherapy. How to find us https://www.tuh.ie/Adult-Services/How-to-find-us/ The Amber Oncology Day Unit is situated on the ground floor of the main hospital building, turn right onto Hospital Street (after lifts) and is the second turn to the left off the main Hospital Street when approaching from the main hospital entrance. Main ODW contact numbers: 01 414 4255/ 01 414 4256 |
||||||||||||
Mission StatementThe Amber Oncology Dayward aims to provide a safe and comfortable environment for cancer patients undergoing cancer treatment. We strive to provide a high standard of care with a holistic approach to all our patients. The values and beliefs underpinning the ward are: Respect for the patient and for the independence and autonomy of each individual
|
||||||||||||
Inpatient ServiceInpatient care is delivered to medical oncology patients in TUH by the consultant-led medical teams, nursing staff and allied health professionals including our oncology specific Dietitian and Medical Social Worker. This is delivered on inpatient wards throughout the Hospital. |
||||||||||||
Medical Team
Dr. Lynda Corrigan is a consultant medical oncologist in TUH, also working within the Dublin Midlands Hospital Group with a weekly clinic in Naas General Hospital, and working with colleagues in St. James’s Hospital to advance patients access to clinical trials across the hospital group.|
Dr. Corrigan was awarded the ISMO Advanced Oncology Fellowship and undertook this in the Royal Marsden Hospital in Surrey, UK. She has published original research in genitourinary and gastrointestinal cancers in peer reviewed journals. Dr. Corrigan treats predominantly genitourinary and gastrointestinal cancers and is a principal investigator in a number of clinical trials run through TUH 
Professor Kelleher trained in melanoma in the world-famous Peter Mac Callum Cancer Institute, Melbourne, Australia prior to taking up appointment in 2016 as a Consultant Medical Oncologist. In St James's Hospital he is the Medical Oncology lead for melanoma as well as treating other cutaneous malignancies. He is co-clinical lead for the Cancer Immunology Research Theme TSJCI.
Professor Kelleher graduated from University College Cork and undertook initial training in surgery and internal medicine prior to specialising in Medical Oncology. Professor Kelleher is a Fellow of the Royal College of Physicians of Ireland, Fellow of The Royal College of Physicians of London, and Associate Fellow Royal College of Surgeons in Ireland. He holds a Master of Science degree, and Medical Doctorate. Professor Kelleher has over 55 publications in International Peer Reviewed Journals including Clinical Cancer Research, Cancer Letters, European Journal of Cancer, Annals of Internal Medicine, and Carcinogenesis. He has served as peer reviewer for over 50 journals including Proceedings of The Royal Society Transactions B, Cancer Research (AACR), and British Journal of Cancer. He is a principal investigator for Medical Oncology Clinical Trials in the sub-specialty of melanoma conducted in St James's Hospital & TUH. 
Dr. Trainor is a Consultant Medical Oncologist in TUH and Naas General Hospital. He graduated from Trinity College Dublin and began his medical training in Ireland before moving to Leeds, UK, to take up Specialty Registrar training in Medical Oncology. Whilst in Leeds he was awarded the Tony Bramall Fellowship during which he completed a laboratory-based PhD focusing on the discovery and validation of novel therapeutic targets in renal cell carcinoma.
He worked as a Consultant Medical Oncologist in St James University Hospital in Leeds during which he was involved in a number of clinical trials in breast cancer. He returned home to Ireland to take up his current post where he has a subspecialist interest in lung and thoracic malignancies. He continues to have a particular interest in bringing clinical trial opportunities for patients with cancer in Ireland. He is a Fellow of the Royal College of Physicians, London, and a Member of the Royal College of Physicians of Ireland. 
Professor McDermott trained in Medical Oncology in Dublin during which time he completed an MBA in Health Services Management. From there, he went to the Institut Curie, Paris where he earned a PhD. He completed his clinical training at Fox Chase Cancer Center, Philadelphia where he furthered an interest in Genito-Urinary Oncology. He then returned to Ireland as Consultant Medical Oncologist.
Professor McDermott subsequently took over as Clinical Lead of Cancer Trials Ireland and facilitated an organisational restructure with appointment of an independent Board of Directors and development of a strategic vision for cancer trials in Ireland. He then successfully led the grant renewal programme with an award of €9,000,000 over three years. He continues to pursue research interests in genito-urinary and pancreas cancer and has received awards to run clinical trials in Ireland with associated funding of several million euros. He has devised and been national co-ordinator on multiple clinical studies. He is currently accruing patients to over 30 studies and estimates to accrue 15% of patients see on trial. In 2016, he was appointed Clinical Professor in Medical Oncology by University College Dublin. He is committed to improving outcomes for Irish patients with cancer through clinical and translational research. 
Dr. Greene is a medical oncologist who attends the GI Cancer MDM at Tallaght University and runs a satellite oncology clinic at Naas Hospital
|
